CLDN7 and inflammatory bowel disease: Research has shown that LPS causes significant damage to intestinal morphology in vivo, reduces mRNA expression of tight junction proteins (Occludin and Claudin1), increases pro-inflammatory cytokine expression, and elevates reactive oxygen species (ROS) content both in vivo and in vitro, validating the IBD model establishment.